More stories

  • in

    Rocket Lab revenue increases slightly, company adds NASA launch contract

    Rocket Lab’s revenue increased slightly in the first quarter, but losses grew as well.
    The spacecraft and launch company added a NASA contract and announced the delivery of its first Photon spacecraft for in-space manufacturing company Varda.
    The company said an increase in R&D spending for its Neutron rocket and Photon spacecraft drove a rise in expenses.

    Electron rockets undergo preparation for launch.
    Rocket Lab

    Rocket Lab’s revenue increased slightly in the first quarter, but losses grew as well, as the spacecraft and launch company added a NASA contract and continued to invest in its future Neutron vehicle.
    The company reported a net loss of $45.6 million, or 10 cents per share, wider than the net loss of $26.7 million, or 6 cents per share, that it reported a year earlier. On an adjusted EBITDA basis, the company lost $26.2 million, compared with loss of $8 million in the same period a year ago.

    Rocket Lab said an increase in R&D spending for its Neutron rocket and Photon spacecraft drove a rise in expenses.
    Revenue grew in the first quarter to $54.9 million – up about 6% from the prior quarter and about 35% from the same quarter last year. The company’s rocket business brought in $19.6 million, thanks to three launches during the quarter, while its space systems division saw revenue of $35.3 million, down from $39.8 million in the prior quarter.
    “At a time when we’re starting to see a contraction of available small rockets, we’re also seeing an increase in launch bookings for Electron launches in 2023 and beyond from new and returning customers across government and commercial sectors. The development of our larger rocket Neutron is continuing at pace,” Rocket Lab founder and CEO Peter Beck said in a statement.
    Rocket Lab’s order backlog decreased slightly to $494.2 million, as the company “recognized strong revenue in the quarter, combined with some larger potential deals taking longer to close.”
    It had $450 million in cash on hand at the quarter’s end, down from $484.3 million the prior quarter.

    Shares of Rocket Lab were little changed in after-hours trading from its close at $3.94 a share. The company’s stock is up 4.5% so far this year.

    Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

    Rocket Lab made a pair of announcements alongside its quarterly results, including a deal with NASA to launch its Starling mission of “swarm” satellites on Electron in the third quarter. The company noted that it “will deliver the satellites to space within three months of the contract signing.”
    It also announced the delivery of its first Photon spacecraft developed for in-space manufacturing company Varda, which is expected to launch “no earlier than June 8.” More

  • in

    Gilead Sciences defeats U.S. government lawsuit alleging HIV drug patent violations

    A jury cleared Gilead Sciences of U.S. government allegations that it violated patents held by the Centers for Disease Control and Prevention on an HIV prevention drug.
    The government had sued Gilead in 2019 arguing that the company was profiting off CDC patents through the company’s sales of Truvada and Descovy.
    But jurors after a multiday trial found that the government’s patent claims on the HIV prevention regimen called pre-exposure prophylaxis, or PrEP, were not valid.

    The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.
    Mike Blake | Reuters

    A Delaware federal court jury on Tuesday cleared Gilead Sciences of civil claims by the U.S. government that the company violated patents held by the Centers for Disease Control and Prevention for an HIV prevention drug.
    The government sued Gilead in 2019, arguing that the company was profiting off CDC patents through the company’s sales of Truvada and Descovy, oral medications taken to prevent HIV infection.

    But jurors after a multiday trial found that the government’s patent claims on the HIV prevention regimen called pre-exposure prophylaxis, or PrEP, were not valid.
    “Today’s decision confirms our longstanding belief that we have always had the rights to make Truvada and Descovy for PrEP available to all who need it,” said Gilead general counsel Deb Telman in a statement.
    “Gilead will continue to champion collaborations, including our efforts with the U.S. Health and Human Services Department (HHS) and CDC that span more than 15 years, as we all work together toward our common goal to end the HIV epidemic for everyone, everywhere,” Telman said.
    HHS, the parent entity of the CDC, did not immediately respond to a request for comment on the verdict.
    Gilead’s combined worldwide sales of Truvada and Descovy were about $2 billion in 2022, according to company financial statements.

    The government claimed that the CDC in the mid-2000s discovered that two drugs, emtricitabine and tenofovir, were highly effective in preventing HIV infection.
    Truvada and Descovy both contain emtricitabine and tenofovir. But Gilead said it invented these drugs, and that the concept of using Truvada to prevent HIV was well-known when the U.S. government filed for the patents.
    PrEP has played a crucial role in reducing the number of new HIV infections in communities that face a higher risk from the virus, such as men who have sex with other men.
    Scientists have tried for decades to develop a vaccine against HIV. But those efforts to date have been unsuccessful.
    About 40 million people worldwide have died from HIV since the epidemic began in the 1980s, according to the World Health Organization. More than 80 million people have been infected.
    In 2021, there were 38 million people living with HIV, according to WHO data.
    Correction: This story has been updated to reflect the correct name of the Centers for Disease Control and Prevention. More

  • in

    Virgin Galactic quarterly loss widens while company preps for spaceflight return

    Virgin Galactic is aiming to fly its first spaceflight in nearly two years later this month.
    But the space tourism company’s first quarter loss widened as it funds its fleet growth.
    Virgin Galactic cited “increases in research and development expenses,” in a press release.

    An aerial view of carrier aircraft VMS Eve, left, and spacecraft VSS Unity, at Spaceport America in New Mexico on Feb. 27, 2023.
    Virgin Galactic

    Virgin Galactic is aiming to fly its first spaceflight in nearly two years later this month, but the company’s first quarter loss widened dramatically as it funds its fleet growth.
    For the quarter ended March 31, Virgin Galactic posted a net loss of $159.4 million, or 57 cents a share, compared with a loss of $93.1 million, or 36 cents a share, a year earlier.

    Virgin Galactic had cash and securities totaling $874 million at the end of the quarter, down from about $980 million at the end of the fourth quarter. It reported minimal revenue.

    Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

    Virgin Galactic cited “increases in research and development expenses,” in a press release. CEO Michael Colglazier said the company is “making steady progress on the development of our Delta Class spaceships.”
    The company is preparing to launch its VSS Unity spacecraft for the first time since flying Sir Richard Branson in July 2021. The next spaceflight, scheduled for the end of May, will carry a crew of company employees on a mission to verify its work. It paused launches for a lengthy refurbishment period of its vehicles, with Virgin Galactic aiming to fly its first commercial mission in “late June.”
    The space tourism company reported an adjusted EBITDA loss of $140 million, compared with a $77 million loss in the same period a year ago.
    Shares of Virgin Galactic stock slipped more than 1% in after-hours trading, from its close at $4.09 a share. The stock is up about 17% since this beginning of the year. More

  • in

    Fox posts quarterly loss on Dominion settlement despite boost from Super Bowl, Tubi

    Fox reported a $54 million net loss in its fiscal third quarter due to the costs associated with Fox News’ settlement with Dominion.
    Last month, Fox agreed to pay $787.5 million to Dominion Voting Systems to settle a defamation lawsuit over false claims that Dominion’s machines swayed the outcome of the 2020 presidential election.
    Fox CEO Lachlan Murdoch said Tuesday the company made the “business decision” to settle and avoid the acrimony of a public six-week trial, and likely years of appeals that would follow.

    The News Corporation headquarters, which is also home to Fox News, stands in Manhattan on April 18, 2023 in New York City.
    Spencer Platt | Getty Images

    Fox Corp. reported a quarterly net loss on Tuesday due to the costs related to its settlement with Dominion Voting Systems, despite revenue that was lifted by the Super Bowl and its fast ad-supported streaming service Tubi.
    Fox notched $4.08 billion in quarterly revenue, up 18% from the same period last year. Its advertising revenue soared on the back of the Super Bowl — the most watched program in U.S. TV history with 115 million viewers, which brought in approximately $650 million in gross ad revenue. The company also saw a boost after airing more NFL games during the season and from increased viewership for Tubi.

    related investing news

    The company said Tuesday it swung to a $54 million net loss, or 10 cents per share, in its fiscal third quarter ended on March 31, from a profit of $283 million, or 50 cents per share, in the year-earlier period on charges associated with settlement costs.
    Last month, Fox agreed to pay $787.5 million to Dominion to settle a defamation lawsuit over false claims the company’s voting machines swayed the outcome of the 2020 presidential election.
    While the company is unlikely to see a big dent in its bottom line from the Dominion case, it did face elevated legal costs in recent quarters related to the lawsuit due to depositions and pretrial preparation, finance chief Steve Tomsic said Tuesday.
    Executives added they didn’t expect the litigation costs to affect share buybacks.
    The settlement stopped in its tracks a trial that was slated to include appearances from top executives including Chairman Rupert Murdoch, as well as Fox News talent, on the witness stand.

    “We made the business decision to resolve this dispute and avoid the acrimony of a divisive trial and a multiyear appeal process, a decision clearly in the best interests of the company and its shareholders,” CEO Lachlan Murdoch said on Tuesday’s earnings call. “The settlement in no way alters Fox’s commitment to the highest journalistic standards across our company or our passion for unabashedly reporting the news of the day.”
    The CEO said on Tuesday that the Delaware court had “severely limited” its defenses due to a pretrial ruling. Among the challenges he pointed to was the judge’s ruling that Fox could not use newsworthiness as a defense.
    The company has previously said, and Lachlan Murdoch echoed Tuesday, that Fox “always acted as a news organization, reporting on the newsworthy events of the day,” which includes allegations that were being made publicly by then-President Donald Trump and his allies. Fox has argued it was protected by the First Amendment, which the CEO echoed on Tuesday when discussing the remaining defamation lawsuit Fox faces from Smartmatic USA, another voting-tech company.
    Lachlan Murdoch noted the Smartmatic case is moving at a “fundamentally different pace” than Dominion, as it is likely to go to trial in 2025, but that all of Fox’s First Amendment defense remains.
    Soon after the settlement with Dominion was announced, the network fired top on-air host Tucker Carlson, a surprising move for the network which has seen high ratings for the prime-time program “Tucker Carlson Tonight.”
    On Tuesday, the Fox CEO said there would be no changes to prime-time programming strategy, noting the network is “always adjusting our programming and our lineup and that’s what we continue to do.” Fox is the top-rated cable news channel, even as prime-time ratings in Carlson’s slot have slid since his departure. More

  • in

    Under Armour sends potential warning sign about retailers’ profits

    Under Armour fell short on profit margins in the fiscal fourth quarter, despite beating earnings and revenue expectations.
    The retailer chalked that up to higher promotions.
    Its results could signal that to move merchandise, retailers may be back to offering deep discounts.

    People walks past a Under Armour clothing store in Siam Center, Bangkok.
    Guillaume Payen | SOPA Images | LightRocket | Getty Images

    Under Armour’s shares sank Tuesday, even after the athletic apparel and footwear retailer beat Wall Street’s quarterly revenue and earnings expectations.
    The reason for the drop may offer insights into challenges faced by other retailers.

    The company drove higher sales, in part, by offering lower prices. Under Armour missed fiscal fourth-quarter expectations on gross margin as it leaned more on promotions than expected.
    Shares fell more than 6% in afternoon trading.
    The company’s finance chief David Bergman chalked up the margin decline to higher promotions as Under Armour marked down merchandise from prior seasons and sold it through off-price retail.
    Under Armour warned the issues could persist. The company said it expects margins will still be under pressure as higher promotions outweigh lower freight costs. Diluted earnings per share are expected to range between a loss of 3 cents to a loss of 5 cents in the first quarter, below expected earnings of 6 cents per share, according to FactSet. It said it expects margins to improve as the year goes on.
    Under Armour’s results could spell trouble for retailers that report quarterly results in the coming weeks. The report could signal that to move merchandise, companies may have to offer discounts and sacrifice more of their profits.

    In the coming weeks, retailers including Walmart, Target, Best Buy and Macy’s, will shine a light on consumer health and reveal how much pricing power they have. It will also help illustrate how much of Under Armour’s issues are specific to the company, rather than representative of the broader industry and economic backdrop.
    Promotion levels have swung dramatically due to pandemic-related trends. During the early years of Covid, retailers had lower-than-usual markdowns as they struggled to keep shelves stocked due to supply chain delays. They then benefited from huge consumer spending fueled by stimulus payments.
    The pendulum swung last spring, however. Target, Kohl’s, Gap and others suddenly had a glut of extra inventory — including a lot of popular pandemic categories like patio furniture and athleisure that had fallen out of favor. The excess supply ushered in a wave of deep discounts.
    Now, retailers are dealing with another dynamic. Consumers are thinking twice about discretionary spending as they rack up bigger bills at the grocery store or book trips instead of filling up their closets.
    Simeon Siegel, a retail analyst for BMO Capital Markets, said the pandemic gave retailers a chance to press the reset button. Their resolve, however, has faded.
    “Very few companies have the fortitude to forgo volume for the sake of profits outside of a global pandemic,” he said. “It’s very easy to fall back to the promotional drug when push comes to shove.”
    As higher transportation and supply chain costs roll off, he expects many retailers won’t see the benefit because they are “returning to the promotions cookie jar.”
    The company’s results reflect company-specific challenges along with consumer trends. The company recently tapped Stephanie Linnartz as its new CEO to lead efforts to grow its online business, refresh its brand and better compete with rivals Nike and Lululemon. She stepped into the role in late February.
    Some of the company’s weakest sales in the recent quarter came from North America. Net sales in the region grew 2.5% in the three-month period compared with 13.8% growth in Europe and the 23.6% growth in the Asia-Pacific region.
    On an earnings call, Linnartz said the company is “continuing to navigate a legacy of higher than desired promotional activities in our home market.”
    She said the apparel and footwear brand bears part of the blame for the trend due to inconsistent marketing and underwhelming presentation in stores. She said the company will strengthen its brand in the coming year.
    Inventory levels are still a factor for some retailers, too. As of the end of the quarter, Under Armour had nearly $1.2 billion in inventory, up 44% year over year.
    Bergman said about half of that is inventory that Under Armour has chosen to pack and hold for future sales.
    For its fiscal fourth quarter, Under Armour reported adjusted earnings per share of 18 cents, higher than analysts’ expectations of 15 cents per share, according to Refinitiv.
    The company’s net income for the three-month period that ended March 31 was $170.5 million, or 38 cents per share, compared with a net loss of $59.6 million, or 13 cents per share, during the year-earlier period. Sales jumped 8% to $1.4 billion from $1.3 billion in the year-ago period. That exceeded analysts’ expectations of $1.36 billion, according to Refinitiv.
    — Robert Hum contributed to this story. More

  • in

    Just how good can China get at generative AI?

    IF YOU LISTEN to the bombastic rhetoric in Beijing and Washington, America and China are engaged in an all-out contest for technological supremacy. “Fundamentally, we believe that a select few technologies are set to play an outsized importance over the coming decade,” thundered Jake Sullivan, President Joe Biden’s national security adviser, last September. In February Xi Jinping, China’s paramount leader, echoed the sentiment, stating that “we urgently need to strengthen basic research and solve key technology problems” in order to “cope with international science and technology competition, achieve a high level of self-reliance and self-improvement”. No technology seems to obsess policymakers on both sides of the Pacific more right now than artificial intelligence (AI). The rapid improvements in the abilities of “generative” AIs like ChatGPT, which analyse the web’s worth of human text, images or sounds and can then create increasingly passable simulacrums, have only strengthened the obsession. If generative AI proves as transformational as its boosters claim, the technology could give those who wield them an economic and military edge in the 21st century’s chief geopolitical contest. Western and Chinese strategists already talk of an AI arms race. Can China win it?On some measures of AI prowess, the autocracy pulled ahead some time ago (see chart 1). China surpassed America in the share of highly cited AI papers in 2019; in 2021 26% of AI conference publications globally came from China, compared with America’s share of 17%. Nine of the world’s top ten institutions, by volume of AI publications, are Chinese. According to one popular benchmark, so are the top five labs working on computer vision, a type of AI particularly useful to a communist surveillance state.At the same time, when it comes to “foundation models”, which give the buzzy generative AIs their wits, America finds itself firmly in front (see chart 2). ChatGPT and the pioneering model behind it, the latest version of which is called GPT-4, are the brain child of OpenAI, an American startup. A handful of other American firms, from small firms such as Anthropic or Stability AI to tech giants like Google, Meta and Microsoft (which part-owns OpenAI), have their own powerful systems. ERNIE, a Chinese rival to ChatGPT built by Baidu, China’s internet-search giant, is widely seen as less clever than most of them (see chart 3). Alibaba and Tencent, China’s mightiest tech titans, have yet even to unveil their own generative AIs. This leads those in the know to conclude that China is two or three years behind America in foundation-model building. There are three reasons for this underperformance. The first concerns data. On the surface, a centralised autocracy should be able to marshal a lot of it—the government was, for instance, able to hand over its troves of surveillance information on Chinese citizens to companies such as SenseTime or Megvii that, with the help of the country’s leading computer-vision labs, then used it to develop top-notch facial-recognition systems. That advantage has proved less formidable in the context of generative AIs, because foundation models are trained on the much more voluminous unstructured data of the internet. American model-builders benefit from the fact that 56% of all websites are in English, whereas just 1.5% are in Mandarin or China’s other languages, according to data from the W3Techs, an internet-research site. As Yiqin Fu of Stanford University points out, the Chinese interact with the internet primarily through mobile super-apps like WeChat and Weibo. These are “walled gardens”, so much of their content is not indexed on search engines. This makes that content harder for AI models to suck up. Lack of data may explain why Wu Dao 2.0, a Chinese model unveiled in 2021 by the Beijing Academy of Artificial Intelligence, a state-backed outfit, failed to make a splash despite its possibly being more computationally complex than GPT-4.The second reason for China’s lacklustre generative achievements has to do with hardware. Last year America imposed swingeing export controls on any technology that might give its main geostrategic rival a leg-up in AI. In particular, that includes the powerful chips used in the cloud-computing data centres where foundation models do their learning, and the chipmaking tools that could enable China to build such semiconductors on its own. That was a blow to Chinese model-builders. An analysis of 26 big Chinese models by the Centre for the Governance of AI, a British think-tank, found that more than half depended on Nvidia, an American chip designer, for their processing power. Some reports suggest that SMIC, China’s biggest chip manufacturer, has produced prototype chips which are just a generation or two behind TSMC, the Taiwanese industry leader that manufactures chips for Nvidia (see chart 4). But the Chinese firm may only be able to mass-produce chips which TSMC was churning out by the million three or four years ago. A professor at a leading Chinese university laments his country’s weakness in such “basic infrastructure” of AI.Chinese AI firms are also having more trouble getting their hands on another American export: know-how. America remains a magnet for the world’s tech talent; two-thirds of AI experts in America who present papers at the biggest AI conference are foreign-born. Chinese engineers made up 27% of that select group in 2019. Many Chinese AI boffins studied or worked in America before bringing their machine learnings back home. (Few non-Chinese boffins would consider moving to a police state a wise career move.) The covid-19 pandemic and rising Sino-American tensions are causing their numbers to dwindle. In the first half of 2022 America granted half as many visas to Chinese students as in the same period in 2019. The triple shortage—of data, hardware and expertise—has been a genuine hurdle for China. Whether it will hold Chinese AI ambitions back much longer is, though, another matter. Info attainmentTake data. On February 13th the local authorities in Beijing, where nearly a third of China’s AI firms are located, said they were releasing data from 115 state-affiliated organisations, giving model-builders 15,880 data sets to play with. To liberate more data, the central government also wants to dismantle Chinese apps’ walled gardens. Most important, the latest models appear able to transfer learnings from one language to another. In the paper describing GPT-4, OpenAI said that the model performed remarkably well on tasks in Chinese despite the dearth of Chinese source material in the model’s training data. Already Baidu’s ERNIE was trained on lots of English-language data, notes Jeffrey Ding of George Washington University. In hardware, too, China is finding workarounds. The Financial Times reported in March that SenseTime, which is blacklisted by America’s government, has used intermediaries to skirt the export controls. Some Chinese AI firms are able to harness the computing power of Nvidia’s advanced chips through cloud servers based in other countries. Alternatively, they can simply buy more of Nvidia’s less advanced semiconductors or use them more efficiently with the help of clever software. To continue serving the vast Chinese market, the American company has designed less powerful sanctions-compliant processors. These are between 10% and 30% slower than its top-of-the-range kit, and end up being costlier for the Chinese customers per unit of processing power. But they do the job. China could partly alleviate the dearth of chips—and of brain power—with the help of “open-source” models. Such models’ inner workings can be downloaded by anyone and fine-tuned to a specific task. Most importantly, that includes the numbers, called “weights”, which define the structure of the model and which are derived from costly training runs. Alpaca, a model built by researchers at Stanford University using the weights from LLaMA, a foundation model created by Meta, was made for less than $600, compared with sums on the order of $100m for training something like GPT-4. Alpaca performs just as well as the original version of ChatGPT on many tasks. Chinese AI labs could similarly avail themselves of open-source models, which embody the collective wisdom of international research teams. Matt Sheehan of the Carnegie Endowment for International Peace, another think-tank, says that China has form in being a “fast follower”—its labs have absorbed advances from abroad and then rapidly incorporated them into their own models, often with flush state resources. A prominent Silicon Valley venture capitalist is more blunt, calling open-source models a gift to the Communist Party.Such considerations make it hard to imagine that either America or China could in the long run build an unbridgeable lead in AI modelling. Each may well end up with AIs of roughly similar ability, even if it costs China over the odds to keep up in the face of American sanctions. But even if the race of the model-builders is a dead heat, America has one thing going for it that could make it the big AI winner—its peerless ability to spread cutting-edge innovation throughout the economy. It was, after all, more efficient diffusion of technology that helped America open up a technological lead over the Soviet Union, which in the 1950s was producing twice as many science PhDs as its democratic adversary.China is, of course, far more competent than the Soviet Union ever was at adopting new technologies. Its fintech platforms, 5G telecoms and high-speed rail are all world-class. But those successes may be the exception, not the rule, says Mr Ding. Particularly, in the deployment of sensors, cloud computing and business software—all complementary to AI—China has done less well. Although American export controls may not derail all Chinese model-building, they do constrain China’s tech industry more broadly, thereby slowing the adoption of any new technology. Moreover, corporate China as a whole, and especially small and medium-sized companies, is short of technologists who act as conduits for technological diffusion. Swathes of the economy are dominated by state-owned firms, which tend to be stodgy and change-averse. China’s “Big Fund” for chips, which raised $50bn in 2014 with a view to backing domestic semiconductor firms, has been mired in scandals. Many of the thousands of AI startups created in recent years have simply slapped on the AI label in the hope of getting a slice of the lavish subsidies doled out by the state to the favoured industry. As a consequence, China’s private sector may find it hard to take full advantage of generative AI, especially if the Communist Party imposes heavy regulations to prevent chatbots from saying something its censors do not like. Such handicaps would come on top of Mr Xi’s broader suborning of private enterprise, including a two-and-a-half-year crackdown on China’s tech industry. Although this anti-tech campaign has officially ended, it has left businesses scarred. The result is a chill in tech sentiment. Last year private investments in Chinese AI startups amounted to $13.5bn, less than one-third the amount that flowed to their American rivals. In the first four months of 2023 the funding gap appears only to have widened, according to PitchBook, a data provider. Whether or not generative AI proves revolutionary, the free market has placed its bet on who will make the most of it. ■ More

  • in

    Just how good can China get at AI?

    IF YOU LISTEN to the bombastic rhetoric in Beijing and Washington, America and China are engaged in an all-out contest for technological supremacy. “Fundamentally, we believe that a select few technologies are set to play an outsized importance over the coming decade,” thundered Jake Sullivan, President Joe Biden’s national security adviser, last September. In February Xi Jinping, China’s paramount leader, echoed the sentiment, stating that “we urgently need to strengthen basic research and solve key technology problems” in order to “cope with international science and technology competition, achieve a high level of self-reliance and self-improvement”. No technology seems to obsess policymakers on both sides of the Pacific more right now than artificial intelligence (AI). The rapid improvements in the abilities of “generative” AIs like ChatGPT, which analyse the web’s worth of human text, images or sounds and can then create increasingly passable simulacrums, have only strengthened the obsession. If generative AI proves as transformational as its boosters claim, the technology could give those who wield them an economic and military edge in the 21st century’s chief geopolitical contest. Western and Chinese strategists already talk of an AI arms race. Can China win it?On some measures of AI prowess, the autocracy pulled ahead some time ago (see chart 1). China surpassed America in the share of highly cited AI papers in 2019; in 2021 26% of AI conference publications globally came from China, compared with America’s share of 17%. Nine of the world’s top ten institutions, by volume of AI publications, are Chinese. According to one popular benchmark, so are the top five labs working on computer vision, a type of AI particularly useful to a communist surveillance state.At the same time, when it comes to “foundation models”, which give the buzzy generative AIs their wits, America finds itself firmly in front (see chart 2). ChatGPT and the pioneering model behind it, the latest version of which is called GPT-4, are the brain child of OpenAI, an American startup. A handful of other American firms, from small firms such as Anthropic or Stability AI to tech giants like Google, Meta and Microsoft (which part-owns OpenAI), have their own powerful systems. ERNIE, a Chinese rival to ChatGPT built by Baidu, China’s internet-search giant, is widely seen as less clever than most of them (see chart 3). Alibaba and Tencent, China’s mightiest tech titans, have yet even to unveil their own generative AIs. This leads those in the know to conclude that China is two or three years behind America in foundation-model building. There are three reasons for this underperformance. The first concerns data. On the surface, a centralised autocracy should be able to marshal a lot of it—the government was, for instance, able to hand over its troves of surveillance information on Chinese citizens to companies such as SenseTime or Megvii that, with the help of the country’s leading computer-vision labs, then used it to develop top-notch facial-recognition systems. That advantage has proved less formidable in the context of generative AIs, because foundation models are trained on the much more voluminous unstructured data of the internet. American model-builders benefit from the fact that 56% of all websites are in English, whereas just 1.5% are in Mandarin or China’s other languages, according to data from the W3Techs, an internet-research site. As Yiqin Fu of Stanford University points out, the Chinese interact with the internet primarily through mobile super-apps like WeChat and Weibo. These are “walled gardens”, so much of their content is not indexed on search engines. This makes that content harder for AI models to suck up. Lack of data may explain why Wu Dao 2.0, a Chinese model unveiled in 2021 by the Beijing Academy of Artificial Intelligence, a state-backed outfit, failed to make a splash despite its possibly being more computationally complex than GPT-4.The second reason for China’s lacklustre generative achievements has to do with hardware. Last year America imposed swingeing export controls on any technology that might give its main geostrategic rival a leg-up in AI. In particular, that includes the powerful chips used in the cloud-computing data centres where foundation models do their learning, and the chipmaking tools that could enable China to build such semiconductors on its own. That was a blow to Chinese model-builders. An analysis of 26 big Chinese models by the Centre for the Governance of AI, a British think-tank, found that more than half depended on Nvidia, an American chip designer, for their processing power. Some reports suggest that SMIC, China’s biggest chip manufacturer, has produced prototype chips which are just a generation or two behind TSMC, the Taiwanese industry leader that manufactures chips for Nvidia (see chart 4). But the Chinese firm may only be able to mass-produce chips which TSMC was churning out by the million three or four years ago. A professor at a leading Chinese university laments his country’s weakness in such “basic infrastructure” of AI.Chinese AI firms are also having more trouble getting their hands on another American export: know-how. America remains a magnet for the world’s tech talent; two-thirds of AI experts in America who present papers at the biggest AI conference are foreign-born. Chinese engineers made up 27% of that select group in 2019. Many Chinese AI boffins studied or worked in America before bringing their machine learnings back home. (Few non-Chinese boffins would consider moving to a police state a wise career move.) The covid-19 pandemic and rising Sino-American tensions are causing their numbers to dwindle. In the first half of 2022 America granted half as many visas to Chinese students as in the same period in 2019. The triple shortage—of data, hardware and expertise—has been a genuine hurdle for China. Whether it will hold Chinese AI ambitions back much longer is, though, another matter. Info attainmentTake data. On February 13th the local authorities in Beijing, where nearly a third of China’s AI firms are located, said they were releasing data from 115 state-affiliated organisations, giving model-builders 15,880 data sets to play with. The central government has previously signalled it wants to dismantle Chinese apps’ walled gardens, potentially liberating more data, says Kayla Blomquist, a former American diplomat in China now at Oxford University.Most important, the latest models appear able to transfer learnings from one language to another. In the paper describing GPT-4, OpenAI said that the model performed remarkably well on tasks in Chinese despite the dearth of Chinese source material in the model’s training data. Already Baidu’s ERNIE was trained on lots of English-language data, notes Jeffrey Ding of George Washington University. In hardware, too, China is finding workarounds. The Financial Times reported in March that SenseTime, which is blacklisted by America’s government, has used intermediaries to skirt the export controls. Some Chinese AI firms are able to harness the computing power of Nvidia’s advanced chips through cloud servers based in other countries. Alternatively, they can simply buy more of Nvidia’s less advanced semiconductors or use them more efficiently with the help of clever software. To continue serving the vast Chinese market, the American company has designed less powerful sanctions-compliant processors. These are between 10% and 30% slower than its top-of-the-range kit, and end up being costlier for the Chinese customers per unit of processing power. But they do the job. China could partly alleviate the dearth of chips—and of brain power—with the help of “open-source” models. Such models’ inner workings can be downloaded by anyone and fine-tuned to a specific task. Most importantly, that includes the numbers, called “weights”, which define the structure of the model and which are derived from costly training runs. Alpaca, a model built by researchers at Stanford University using the weights from LLaMA, a foundation model created by Meta, was made for less than $600, compared with sums on the order of $100m for training something like GPT-4. Alpaca performs just as well as the original version of ChatGPT on many tasks. Chinese AI labs could similarly avail themselves of open-source models, which embody the collective wisdom of international research teams. Matt Sheehan of the Carnegie Endowment for International Peace, another think-tank, says that China has form in being a “fast follower”—its labs have absorbed advances from abroad and then rapidly incorporated them into their own models, often with flush state resources. A prominent Silicon Valley venture capitalist is more blunt, calling open-source models a gift to the Communist Party.Such considerations make it hard to imagine that either America or China could in the long run build an unbridgeable lead in AI modelling. Each may well end up with AIs of roughly similar ability, even if it costs China over the odds to keep up in the face of American sanctions. But even if the race of the model-builders is a dead heat, America has one thing going for it that could make it the big AI winner—its peerless ability to spread cutting-edge innovation throughout the economy. It was, after all, more efficient diffusion of technology that helped America open up a technological lead over the Soviet Union, which in the 1950s was producing twice as many science PhDs as its democratic adversary.China is, of course, far more competent than the Soviet Union ever was at adopting new technologies. Its fintech platforms, 5G telecoms and high-speed rail are all world-class. But those successes may be the exception, not the rule, says Mr Ding. Particularly in the deployment of sensors, cloud computing and business software—all complementary to AI—China has done less well. Although American export controls may not derail all Chinese model-building, they do constrain China’s tech industry more broadly, thereby slowing the adoption of any new technology. Moreover, corporate China as a whole, and especially small and medium-sized companies, is short of technologists who act as conduits for technological diffusion. Swathes of the economy are dominated by state-owned firms, which tend to be stodgy and change-averse. China’s “Big Fund” for chips, which raised $50bn in 2014 with a view to backing domestic semiconductor firms, has been mired in scandals. Many of the thousands of AI startups created in recent years have simply slapped on the AI label in the hope of getting a slice of the lavish subsidies doled out by the state to the favoured industry. As a consequence, China’s private sector may find it hard to take full advantage of generative AI, especially if the Communist Party imposes heavy regulations to prevent chatbots from saying something its censors do not like. Such handicaps would come on top of Mr Xi’s broader suborning of private enterprise, including a two-and-a-half-year crackdown on China’s tech industry. Although this anti-tech campaign has officially ended, it has left businesses scarred. The result is a chill in tech sentiment. Last year private investments in Chinese AI startups amounted to $13.5bn, less than one-third the amount that flowed to their American rivals. In the first four months of 2023 the funding gap appears only to have widened, according to PitchBook, a data provider. Whether or not generative AI proves revolutionary, the free market has placed its bet on who will make the most of it. ■ More

  • in

    Novavax surges after company unveils job cuts, positive vaccine data

    Shares of Novavax soared after the company unveiled promising new vaccine data and a broad cost-cutting push that includes reducing 25% of its workforce. 
    The announcements are a sign of hope for investors after last quarter when the biotech company raised doubts about its ability to stay in business.
    Novavax is now forecasting 2023 sales of $1.4 billion to $1.6 billion in its first-quarter earnings report.

    A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands.
    Patrick Van Katwijk | Getty Images

    Shares of Novavax jumped more than 25% at one point in premarket trading Tuesday after the company unveiled promising new vaccine data and a broad cost-cutting push that includes major layoffs. 
    The announcements are a sign of hope for investors after last quarter, when the biotech company raised doubts about its ability to stay in business and decided not to provide full-year guidance.

    Novavax is now betting on its cost controls and new vaccines to help it stay afloat, forecasting 2023 sales of $1.4 billion to $1.6 billion, according to its first-quarter earnings report.
    The Gaithersburg, Maryland-based company said its combination vaccine that targets both Covid and the flu produced a strong immune response against the viruses and was well-tolerated in a phase two trial. Novavax shared similar trial results on its stand-alone flu vaccine and new high-dose Covid shot. 
    The company’s Covid vaccine is its lone marketed product after 35 years in business.
    Novavax also announced a global cost-cutting plan, which will involve slashing 25% of the company’s workforce. Approximately 20% of the company’s 2,000 full-time equivalent workers will be impacted, a Novavax spokesperson told CNBC. 
    The plan also involves consolidating the company’s facilities and infrastructure. 

    Novavax expects the plan to reduce 2023 R&D and SG&A expenses by around 20% to 25% compared with those costs in 2022. The company reported R&D expenses of $258 million and SG&A expenses of $162 million last year.
    The plan is also projected to reduce 2024 R&D and SG&A costs by approximately 40% to 50% compared with 2022. 
    “Novavax is focused on significantly reducing our expenses while retaining the key capabilities needed to execute our operating plans,” the company said in the release.
    Novavax still reported a bleak first quarter that missed Wall Street’s estimates.
    The biotech company posted first-quarter sales of $81 million, down from the $704 million it reported during the same period a year ago. Novavax said the steep drop was due to “an emerging seasonal pattern” for Covid vaccines.
    Analysts expected the company to rake in $87.6 million in revenue for the quarter, according to Refinitiv survey.
    Novavax reported a net loss of $294 million, or $3.41 per share, compared to a net income of $203 million, or $2.56 per share, during the first quarter of 2022. Analysts estimated the company would post a loss of $3.46 per share, the Refinitv survey said.
    Novavax shares were down 27% for the year through Monday’s close, putting the company’s market value at roughly $643 million.  
    Novavax’s road to launching its Covid vaccine in the U.S. was rocky.
    The company raced against Pfizer and Moderna to develop the first Covid vaccine early in the pandemic. But Novavax’s efforts were hindered by manufacturing snags and regulatory glitches, placing the company far behind its rivals. 
    Novavax’s shot finally won Food and Drug Administration approval last year, but uptake has been sluggish. 
    The FDA in October also signed off on Novavax’s Covid booster. But most Americans had already opted for Pfizer and Moderna’s updated omicron boosters by then. 
    Novavax’s shot is the first Covid vaccine to use protein technology, a decades-old method for fighting viruses used in routine vaccinations against hepatitis B and shingles. 
    The shot works differently than its mRNA-based counterparts from Pfizer and Moderna but achieves the same outcome: teaching your body how to fight Covid. More